Question

Difficulty: HardEndocrinology and Metabolism

A 67-year-old man comes to the office for follow-up of recent unintentional weight loss, heat intolerance, and palpitations. He has a history of ischemic cardiomyopathy, heart failure with reduced ejection fraction, and paroxysmal atrial fibrillation. His medications include lisinopril, metoprolol succinate, furosemide, apixaban, and amiodarone, which was initiated two years ago for rhythm control. Vital signs show a blood pressure of 135/82135/82 mm Hg and a regular pulse of 105105/min. Physical examination reveals a fine tremor of the outstretched hands, warm and moist skin, and hyperactive deep tendon reflexes. The thyroid gland is not palpably enlarged, and no distinct nodules are appreciated. Laboratory studies show:

Thyroid-stimulating hormone (TSH): <0.01<0.01 μ\mu U/mL
Free thyroxine (T4): 3.83.8 ng/dL
Total triiodothyronine (T3): 210210 ng/dL

Which of the following is the most appropriate diagnostic test to differentiate the underlying mechanism of this patient's thyroid dysfunction?

  1. Color flow Doppler ultrasonography of the thyroidAnswer
  2. B
    Radioactive iodine uptake scan
  3. C
    Measurement of thyrotropin receptor antibodies
  4. D
    Measurement of serum thyroglobulin level
  5. E
    Thyroid fine-needle aspiration biopsy

Answer

Color flow Doppler ultrasonography of the thyroid is the correct diagnostic test to differentiate the mechanism of this patient's thyroid dysfunction.
The correct next step is to perform a color flow Doppler ultrasonography of the thyroid. This patient's presentation of low TSH and elevated free T4/T3 in the setting of chronic amiodarone use is highly consistent with amiodarone-induced thyrotoxicosis (AIT). AIT is categorized into two main types: Type 1 results from iodine-induced overproduction of thyroid hormone (Jod-Basedow phenomenon) in patients with underlying latent thyroid disease (such as a multinodular goiter or Graves disease). Type 2 is a destructive thyroiditis caused by the direct toxic effect of amiodarone on thyroid follicular cells, leading to the release of preformed hormone. It is critical to differentiate between the two because their treatments differ significantly (antithyroid drugs for Type 1 vs. glucocorticoids for Type 2). Standard hyperthyroidism workup usually begins with a radioactive iodine uptake (RAIU) scan; however, the massive iodine content in amiodarone expands the body's iodine pool, which suppresses radioiodine uptake in virtually all these patients, making the RAIU scan useless. Instead, color flow Doppler ultrasonography is the diagnostic test of choice. It will demonstrate normal or increased vascular flow in Type 1 AIT and decreased or absent vascular flow in Type 2 AIT.

Step-by-Step Solution

1
Identify the patient's clinical syndrome and pertinent laboratory findings.
The patient exhibits classic symptoms of hyperthyroidism (weight loss, tremor, heat intolerance) supported by a suppressed TSH and elevated free T4 and T3.
Establishing the biochemical presence of thyrotoxicosis is the necessary first step before investigating its etiology.
2
Correlate the thyrotoxicosis with the patient's medication history.
The patient has been taking amiodarone for two years, pointing to amiodarone-induced thyrotoxicosis (AIT).
Amiodarone is heavily iodinated and known to cause both hypothyroidism and thyrotoxicosis. Identifying it as the culprit dictates the subsequent diagnostic pathway.
3
Determine the necessary testing to classify the specific type of AIT.
Recognize that AIT is divided into Type 1 (iodine-induced increased synthesis) and Type 2 (destructive thyroiditis), and that standard tests like a radioactive iodine uptake scan are ineffective due to the systemic iodine load.
Differentiation is critical because Type 1 is treated with antithyroid drugs (e.g., methimazole), whereas Type 2 requires glucocorticoids. Color flow Doppler ultrasound is required to differentiate them based on vascularity.

Key Concept

Amiodarone-induced thyrotoxicosis (AIT) differentiation
Rate this question